<DOC>
	<DOC>NCT01086215</DOC>
	<brief_summary>The Registry involves the collection of information for research and educational purposes only on the use of AngioJet in the peripheral vascular system.</brief_summary>
	<brief_title>Registry of AngioJet Use in the Peripheral Vascular System</brief_title>
	<detailed_description>The PEARL II Registry is a prospective, multi-center, observational registry including 500 patients who meet eligibility from up to 50 sites worldwide. Patient participation will be 12 months including post procedure follow-up contact at 3, 6 and 12 months. The study duration is estimated at 36 months. A patient's treatment is determined by the treating physician based on the clinical situation and local practices. In contrast to a randomized, controlled trial, there are no pre-defined experimental interventions.</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Embolism and Thrombosis</mesh_term>
	<criteria>Patient has been treated in the peripheral vascular system with any of the AngioJet System catheters. Patient has provided appropriate consent/authorization per the site's institutional policy and procedure. Patient has previously been enrolled in either the PEARL Registry or the PEARL II Registry in the last 12months.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>